Publicaciones (13) Publicaciones en las que ha participado algún/a investigador/a

2004

  1. Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies

    Haematologica, Vol. 89, Núm. 5, pp. 541-546

  2. Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression

    Scandinavian Journal of Immunology, Vol. 59, Núm. 6, pp. 553-558

  3. Biologic therapy of liver tumors

    Surgical Clinics of North America, Vol. 84, Núm. 2, pp. 673-696

  4. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761

  5. Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens

    International Journal of Cancer, Vol. 110, Núm. 1, pp. 51-60

  6. Inmunidad y terapia génica: Beneficios y riesgos

    Inmunologia, Vol. 23, Núm. 1, pp. 56-62

  7. Inmunoterapia activa en el tratamiento de neoplasias hematológicas

    Anales del sistema sanitario de Navarra, Vol. 27, Núm. 1, pp. 45-62

  8. Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14

    Microbes and Infection, Vol. 6, Núm. 11, pp. 990-995

  9. Pasado, presente y futuro de la vacunación anti-idiotipo.

    Revista de medicina, Vol. 48, Núm. 3, pp. 14-23

  10. Past, present and future of anti-idiotype vaccination

    Revista de medicina de la Universidad de Navarra, Vol. 48, Núm. 3, pp. 14-23

  11. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397

  12. Tratamiento biológico de los tumores hepáticos

    Clínicas quirúrgicas de Norteamérica, Vol. 2, pp. 633-654

  13. Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: Implications for anti-idiotype vaccine development

    Critical Reviews in Oncology/Hematology, Vol. 52, Núm. 1, pp. 1-7